These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24692465)

  • 1. Destination to nowhere: a new look at aggressive treatment for heart failure--a case study.
    O'Neill BJ; Kazer MW
    Crit Care Nurse; 2014 Apr; 34(2):47-55; quiz 56. PubMed ID: 24692465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Destination nowhere: a potential dilemma with ventricular assist devices.
    Bramstedt KA
    ASAIO J; 2008; 54(1):1-2. PubMed ID: 18204307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upstream palliative care for the patient with a left ventricular assist device as destination therapy.
    Byram EK
    Dimens Crit Care Nurs; 2012; 31(1):18-24. PubMed ID: 22156807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular assist devices as destination therapy: a new look at survival.
    Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparedness planning before mechanical circulatory support: a "how-to" guide for palliative medicine clinicians.
    Swetz KM; Kamal AH; Matlock DD; Dose AM; Borkenhagen LS; Kimeu AK; Dunlay SM; Feely MA
    J Pain Symptom Manage; 2014 May; 47(5):926-935.e6. PubMed ID: 24094703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular assist devices: psychosocial challenges in the elderly.
    Marcus P
    Ann Thorac Surg; 2009 Nov; 88(5):e48-9. PubMed ID: 19853075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term use of a left ventricular assist device for end-stage heart failure.
    Rose EA; Gelijns AC; Moskowitz AJ; Heitjan DF; Stevenson LW; Dembitsky W; Long JW; Ascheim DD; Tierney AR; Levitan RG; Watson JT; Meier P; Ronan NS; Shapiro PA; Lazar RM; Miller LW; Gupta L; Frazier OH; Desvigne-Nickens P; Oz MC; Poirier VL;
    N Engl J Med; 2001 Nov; 345(20):1435-43. PubMed ID: 11794191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications in patients with ventricular assist devices.
    Barnes K
    Dimens Crit Care Nurs; 2008; 27(6):233-41; quiz 242-3. PubMed ID: 18953188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure.
    Long EF; Swain GW; Mangi AA
    Circ Heart Fail; 2014 May; 7(3):470-8. PubMed ID: 24563450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HeartMate II left ventricular assist device: a new device for advanced heart failure.
    Delgado R; Bergheim M
    Expert Rev Med Devices; 2005 Sep; 2(5):529-32. PubMed ID: 16293063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of left ventricular assist devices in the treatment of class IV heart failure patients: what the non-heart failure specialist needs to know.
    Ahmed M; Aranda JM; Schofield RS; Bell JM; Reid JA; Klodell CT
    Cardiol Rev; 2013; 21(1):37-41. PubMed ID: 22643346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of advanced chronic heart failure].
    Oliva F; Macera F; Verde A; Frigerio M
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):112S-117S. PubMed ID: 19195318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. REMATCH and beyond: the cost of treating heart failure using an implantable left ventricular assist device.
    Dembitsky WP
    Semin Cardiothorac Vasc Anesth; 2006 Sep; 10(3):253-5. PubMed ID: 16959761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical considerations for ventricular assist device support: a 10-point model.
    Petrucci RJ; Benish LA; Carrow BL; Prato L; Hankins SR; Eisen HJ; Entwistle JW
    ASAIO J; 2011; 57(4):268-73. PubMed ID: 21642842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A call for guidance in the use of left ventricular assist devices in older adults.
    Vitale CA; Chandekar R; Rodgers PE; Pagani FD; Malani PN
    J Am Geriatr Soc; 2012 Jan; 60(1):145-50. PubMed ID: 22239293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethical issues and palliative care in the cardiovascular intensive care unit.
    Swetz KM; Mansel JK
    Cardiol Clin; 2013 Nov; 31(4):657-68, x. PubMed ID: 24188227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.